- Home
- AUPH vs IDT Comparison
AUPH vs IDT Comparison
Compare AUPH & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- IDT
- Stock Information
- Founded
- AUPH 1993
- IDT 1990
- Country
- AUPH Canada
- IDT United States
- Employees
- AUPH N/A
- IDT N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- IDT Telecommunications Equipment
- Sector
- AUPH Health Care
- IDT Telecommunications
- Exchange
- AUPH Nasdaq
- IDT Nasdaq
- Market Cap
- AUPH 1.4B
- IDT 1.4B
- IPO Year
- AUPH 1999
- IDT 1996
- Fundamental
- Price
- AUPH $12.22
- IDT $64.25
- Analyst Decision
- AUPH Strong Buy
- IDT
- Analyst Count
- AUPH 4
- IDT 0
- Target Price
- AUPH $12.25
- IDT N/A
- AVG Volume (30 Days)
- AUPH 1.7M
- IDT 115.3K
- Earning Date
- AUPH 11-06-2025
- IDT 10-07-2025
- Dividend Yield
- AUPH N/A
- IDT 0.37%
- EPS Growth
- AUPH N/A
- IDT 170.83
- EPS
- AUPH 0.42
- IDT 3.79
- Revenue
- AUPH $260,111,000.00
- IDT $1,223,733,000.00
- Revenue This Year
- AUPH $16.92
- IDT $2.59
- Revenue Next Year
- AUPH $14.29
- IDT $0.40
- P/E Ratio
- AUPH $29.10
- IDT $16.97
- Revenue Growth
- AUPH 25.59
- IDT 1.91
- 52 Week Low
- AUPH $6.42
- IDT $36.12
- 52 Week High
- AUPH $12.82
- IDT $71.12
- Technical
- Relative Strength Index (RSI)
- AUPH 61.79
- IDT 57.03
- Support Level
- AUPH $11.57
- IDT $63.74
- Resistance Level
- AUPH $12.82
- IDT $66.22
- Average True Range (ATR)
- AUPH 0.36
- IDT 1.48
- MACD
- AUPH -0.10
- IDT 0.09
- Stochastic Oscillator
- AUPH 52.08
- IDT 56.97
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.